Boston Scientific Corp (NYSE:BSX)

36.54
Delayed Data
As of Oct 19
 -0.99 / -2.64%
Today’s Change
24.54
Today|||52-Week Range
39.44
+47.40%
Year-to-Date
BAX vs. BSX: Which Stock Should Value Investors Buy Now?
Oct 19 / Zacks.com - Paid Partner Content
Barclays Takes Action on Health Care Stocks
Oct 17 / GuruFocus News - Paid Partner Content
Will Boston Scientific's (BSX) Q3 Earnings Reflect Overall Gain?
Oct 17 / Zacks.com - Paid Partner Content
Here's Why You Should Invest in Boston Scientific Stock Now
Oct 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close37.53
Today’s open37.37
Day’s range36.35 - 37.70
Volume8,448,540
Average volume (3 months)6,913,671
Market cap$50.5B
Data as of 4:03pm ET, 10/19/2018

Growth & Valuation

Earnings growth (last year)-70.12%
Earnings growth (this year)+10.79%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.89%
P/E ratio96.2
Price/Sales3.82
Price/Book7.16

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...-1.71-0.71%
ZBHZimmer Biomet Holdin...-1.92-1.52%
ABMDAbiomed Inc-24.21-6.26%
DXCMDexCom Inc-3.85-2.90%
Data as of 4:03pm ET, 10/19/2018

Financials

Next reporting dateOctober 24, 2018
EPS forecast (this quarter)$0.34
Annual revenue (last year)$9.0B
Annual profit (last year)$104.0M
Net profit margin1.15%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael F. Mahoney
Executive Vice President-
Operations
Edward Mackey
Corporate headquarters
Marlborough, Massachusetts

Forecasts